PROTEINASE K MARKET ANALYSIS

Proteinase K Market, By Form (Lyophilized Powder Form, Liquid Form), By Application (Purification of DNA & RNA, In situ Hybridization, Mitochondria Isolation, Enzyme Removal), By End User (Contract Research Organization, Academic Institutes, Biotechnology Companies, Diagnostic Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2023
Code : CMI3548
Pages :160
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

Restraints & Challenges:

Alternative to proteinase K for cloning and protein sequencing

Global Proteinase K Market – Driver

Collaborations by key market players to expand product portfolio

Collaborations by key market players to expand product portfolio
Newer research and development activities in field of proteinase K

Funding for research and development in the biotechnology field

Market players are focused on granting funding to increase research and funding in biotechnology industry, the global proteinase K market is expected to experience considerable expansion in the North American region. For instance, in January 2021, Pfizer Inc., a multinational biotechnology company, announced that as part of its Pfizer Breakthrough Growth Initiative (PBGI), it has invested a total of US$ 120 million in four clinical-stage biotechnology firms. Pfizer is investing up to US$ 500 million in biotechnology firms through PBGI, offering capital and access to Pfizer's scientific expertise to support the continuation of promising clinical development programs that Pfizer may find strategically valuable in the future.